Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesLeukemiaTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticHematopoietic Stem Cell TransplantationTransplantation ConditioningTissue DonorsHematopoietic Stem CellsGraft SurvivalTransplantation ChimeraLeukemia, Myeloid, AcuteBone Marrow PurgingHistocompatibility TestingBone Marrow DiseasesHistocompatibilityBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoiesisBone Marrow ExaminationLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingImmunosuppressive AgentsCyclophosphamideHematologic NeoplasmsTransplantation, IsogeneicKidney TransplantationRecurrenceMice, Inbred C57BLBone Marrow NeoplasmsRadiation ChimeraTime FactorsCytomegalovirus InfectionsLiver TransplantationGraft RejectionImmunosuppressionTreatment OutcomeCombined Modality TherapyAcute DiseaseColony-Forming Units AssayRemission InductionGraft vs Host ReactionCyclosporineHepatic Veno-Occlusive DiseaseBone DensityLymphocyte DepletionT-LymphocytesRetrospective StudiesCell DifferentiationMyelodysplastic SyndromesHLA AntigensSurvival AnalysisLymphoma, Non-HodgkinHematologic DiseasesOpportunistic InfectionsImmunocompromised HostLeukocyte TransfusionNuclear FamilyBone ResorptionChimeraLeukemia, LymphoidTransplantation ImmunologyFatal OutcomeSevere Combined ImmunodeficiencyFlow CytometryStem Cell TransplantationHeart TransplantationLymphocyte TransfusionLeukocyte CountGranulocytesCells, CulturedActuarial AnalysisSpleenSurvival RateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Mice, Inbred BALB CCytarabineLung TransplantationGranulocyte Colony-Stimulating FactorDisease-Free SurvivalPancytopeniaBone NeoplasmsMultiple MyelomaAntilymphocyte SerumCytomegalovirusImmunophenotypingPolymerase Chain ReactionLymphomaPneumonia, ViralBlood Group IncompatibilityInfectionLeukemia, Myelomonocytic, Acute